Carmell Therapeutics Corporation (CTCX) NASDAQ

0.20

+0.0027(+1.39%)

Updated at March 07 04:00PM

Currency In USD

Valuation

Market Cap5.83M
Enterprise Value6.32M
P/E Ratio-4.79
PEG Ratio0.09
Price/Sales Ratio54.47
Price/Book Ratio-12.11
Enterprise/Revenue64.05
Enterprise/EBITDA-0.31

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin-236.55
Operating Margin-99.34

Management Effectiveness

Return On Assets-8.08
Return On Equity4.13

Income Statement

Revenue50,318
Revenue/Share0
Gross Profit43,961
EBITDA-560,658
Net Income-10.37M
Diluted EPS-0.5

Balance Sheet

Total Cash770,047
Total Cash/Share0.01
Total Debt402,188
Total Debt/Equity-0.14
Current Ratio0.16
Book Value Per Share-0.23

Price History

52-Week Change-92.69
52-Week High3
52-Week Low0.17
Moving Average 50 Days0.35
Moving Average 200 Days0.63

Statistics

Average Volume8.24M
Shares Outstanding30.12M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split FactorN/A
Last Split DateN/A